Security key
088786108
BICYCLE THERAPEUTICS PLC - American Depositary Shares, each representing one ordinary share, nominal value 0.01 euro per share (BCYC)
CUSIP: 088786108
Q4 2020 13F Holders as of 31 Dec 2020
- Type / Class
- Equity / American Depositary Shares, each representing one ordinary share, nominal value 0.01 euro per share
- Shares outstanding
- 50,340,741
- Total 13F shares
- 7,328,435
- Share change
- -221,505
- Total reported value
- $131,544,000
- Price per share
- $17.95
- Number of holders
- 27
- Value change
- -$3,975,466
- Number of buys
- 16
- Number of sells
- 5
Report period
Q4 2020
Institutions
27
Top holders
10
BCYC full security history
Newer quarter: Q1 2021
Previous quarter: Q3 2020
BICYCLE THERAPEUTICS PLC SEC filings
BICYCLE THERAPEUTICS PLC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 088786108
Recent filing periods:
Top shareholders of BCYC - BICYCLE THERAPEUTICS PLC - American Depositary Shares, each representing one ordinary share, nominal value 0.01 euro per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD |
13F
|
Company |
3.9%
|
1,957,961
|
$37,299,000 | — | 30 Sep 2020 | |
| SV Health Investors, LLC |
13F
|
Company |
3.8%
|
1,915,274
|
$36,486,000 | — | 30 Sep 2020 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
2.7%
|
1,363,151
|
$25,968,000 | — | 30 Sep 2020 | |
| Atlas Venture Advisors, Inc. |
13F
|
Company |
2.6%
|
1,306,965
|
$24,898,000 | — | 30 Sep 2020 | |
| SAMLYN CAPITAL, LLC |
13F
|
Company |
0.83%
|
418,482
|
$7,972,000 | — | 30 Sep 2020 | |
| FMR LLC |
13F
|
Company |
0.42%
|
211,444
|
$4,028,000 | — | 30 Sep 2020 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.3%
|
151,730
|
$2,890,000 | — | 30 Sep 2020 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.12%
|
59,500
|
$1,133,000 | — | 30 Sep 2020 | |
| Laurion Capital Management LP |
13F
|
Company |
0.12%
|
57,892
|
$1,103,000 | — | 30 Sep 2020 | |
| Verition Fund Management LLC |
13F
|
Company |
0.06%
|
31,031
|
$591,000 | — | 30 Sep 2020 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.05%
|
26,100
|
$497,000 | — | 30 Sep 2020 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.04%
|
20,345
|
$388,000 | — | 30 Sep 2020 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.03%
|
13,481
|
$257,000 | — | 30 Sep 2020 | |
| Pentwater Capital Management LP |
13F
|
Company |
0.02%
|
12,000
|
$229,000 | — | 30 Sep 2020 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
3,989
|
$76,000 | — | 30 Sep 2020 | |
| UBS Group AG |
13F
|
Company |
0%
|
495
|
$9,000 | — | 30 Sep 2020 | |
| Houlihan Financial Resource Group, Ltd. |
13F
|
Company |
0%
|
223
|
$4,000 | — | 30 Sep 2020 | |
| Advisory Services Network, LLC |
13F
|
Company |
0%
|
100
|
$2,000 | — | 30 Sep 2020 |
Institutional Holders of BICYCLE THERAPEUTICS PLC - American Depositary Shares, each representing one ordinary share, nominal value 0.01 euro per share (BCYC) as of Q4 2020
As of 31 Dec 2020,
BICYCLE THERAPEUTICS PLC - American Depositary Shares, each representing one ordinary share, nominal value 0.01 euro per share (BCYC) was held by
27 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,328,435 shares.
The largest 10 holders included
TYBOURNE CAPITAL MANAGEMENT (HK) LTD, SV Health Investors, LLC, Point72 Asset Management, L.P., Atlas Venture Advisors, Inc., SAMLYN CAPITAL, LLC, FMR LLC, VICTORY CAPITAL MANAGEMENT INC, AXA S.A., RENAISSANCE TECHNOLOGIES LLC, and MOODY ALDRICH PARTNERS LLC.
This page lists
27
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2020 vs Q3 2020 Across Filers
Q3 2020 holders
18
Q4 2020 holders
27
Holder diff
9
| Investor | Q3 2020 Shares | Q4 2020 Shares | Share Diff | Share Chg % | Q3 2020 Value $ | Q4 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.